2J8F - Header Asymmetric Unit

HEADER HYDROLASE 25-OCT-06 2J8F

TITLE CRYSTAL STRUCTURE OF THE MODULAR CPL-1 ENDOLYSIN COMPLEXED TITLE 2 WITH A PEPTIDOGLYCAN ANALOGUE (E94Q MUTANT IN COMPLEX WITH TITLE 3 A DISACCHARIDE-PENTAPEPTIDE)

COMPND MOL_ID: 1; COMPND 2 MOLECULE: LYSOZYME; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 2-339; COMPND 5 SYNONYM: ENDOLYSIN, MURAMIDASE, CP-1 LYSIN, CPL-1; COMPND 6 EC: 3.2.1.17; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES

SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACTERIOPHAGE CP-1; SOURCE 3 ORGANISM_TAXID: 10747; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_CELL_LINE: DH1

KEYWDS ANTIMICROBIAL, MUEIN HYDROLASE, BACTERIOLYTIC ENZYME, KEYWDS 2 PNEUMOCOCCAL CELL WALL DEGRADATION, LYSOZYME, HYDROLASE, KEYWDS 3 GLYCOSIDASE, MULTIMODULAR

EXPDTA X-RAY DIFFRACTION

AUTHOR I.PEREZ-DORADO,J.A.HERMOSO

REVDAT 3 24-FEB-09 2J8F 1 VERSN REVDAT 2 28-AUG-07 2J8F 1 REVDAT 1 03-JUL-07 2J8F 0

JRNL AUTH I.PEREZ-DORADO,N.E.CAMPILLO,B.MONTERROSO,D.HESEK, JRNL AUTH 2 M.LEE,J.A.PAEZ,P.GARCIA,M.MARTINEZ-RIPOLL, JRNL AUTH 3 J.L.GARCIA,S.MOBASHERY,M.MENENDEZ,J.A.HERMOSO JRNL TITL ELUCIDATION OF THE MOLECULAR RECOGNITION OF JRNL TITL 2 BACTERIAL CELL WALL BY MODULAR PNEUMOCOCCAL PHAGE JRNL TITL 3 ENDOLYSIN CPL-1. JRNL REF J.BIOL.CHEM. V. 282 24990 2007 JRNL REFN ISSN 0021-9258 JRNL PMID 17581815 JRNL DOI 10.1074/JBC.M704317200

REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.A.HERMOSO,B.MONTERROSO,A.ALBERT,B.GALAN, REMARK 1 AUTH 2 O.AHRAZEM,P.GARCIA,M.MARTINEZ-RIPOLL,J.L.GARCIA, REMARK 1 AUTH 3 M.MENENDEZ REMARK 1 TITL STRUCTURAL BASIS FOR SELECTIVE RECOGNITION OF REMARK 1 TITL 2 PNEUMOCOCCAL CELL WALL BY MODULAR ENDOLYSIN FROM REMARK 1 TITL 3 PHAGE CP-1 REMARK 1 REF STRUCTURE V. 11 1239 2003 REMARK 1 REFN ISSN 0969-2126 REMARK 1 PMID 14527392 REMARK 1 DOI 10.1016/J.STR.2003.09.005 REMARK 1 REFERENCE 2 REMARK 1 AUTH B.MONTERROSO,A.ALBERT,M.MARTINEZ-RIPOLL,P.GARCIA, REMARK 1 AUTH 2 J.L.GARCIA,M.MENENDEZ,J.A.HERMOSO REMARK 1 TITL CRYSTALLIZATION AND PRELIMINARY X-RAY DIFFRACTION REMARK 1 TITL 2 STUDIES OF THE COMPLETE MODULAR ENDOLYSIN FROM CP- REMARK 1 TITL 3 1, A PHAGE INFECTING STREPTOCOCCUS PNEUMONIAE REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 58 1487 2002 REMARK 1 REFN ISSN 0907-4449 REMARK 1 PMID 12198311 REMARK 1 DOI 10.1107/S0907444902011563

REMARK 2 REMARK 2 RESOLUTION. 1.84 ANGSTROMS.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.84 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 64.55 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.12 REMARK 3 NUMBER OF REFLECTIONS : 38759 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.18053 REMARK 3 FREE R VALUE : 0.21520 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.1 REMARK 3 FREE R VALUE TEST SET COUNT : 2960 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.84 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.89 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2180 REMARK 3 BIN R VALUE (WORKING SET) : 0.307 REMARK 3 BIN FREE R VALUE : 0.299 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 155 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2773 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 80 REMARK 3 SOLVENT ATOMS : 333 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.017 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.59 REMARK 3 B22 (A**2) : 1.43 REMARK 3 B33 (A**2) : 0.15 REMARK 3 B12 (A**2) : 0.00 REMARK 3 B13 (A**2) : 0.00 REMARK 3 B23 (A**2) : 0.00 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.017 REMARK 3 BOND ANGLES (DEGREES) : 1.565 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.190 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.092 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.655 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.103 ; 4.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL

REMARK 4 REMARK 4 2J8F COMPLIES WITH FORMAT V. 3.15, 01-DEC-08

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 25-OCT-06. REMARK 100 THE PDBE ID CODE IS EBI-30144.

REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-JUL-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9760 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 47836 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.65 REMARK 200 RESOLUTION RANGE LOW (A) : 64.55 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.3 REMARK 200 DATA REDUNDANCY : 5.4 REMARK 200 R MERGE (I) : 0.12 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 3.30 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.84 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 81.6 REMARK 200 DATA REDUNDANCY IN SHELL : 2.9 REMARK 200 R MERGE FOR SHELL (I) : 0.46 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 0.90 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1H09 REMARK 200 REMARK 200 REMARK: NONE

REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.29 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL

REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 64.63500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 64.63500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 40.11500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 47.79500 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 40.11500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 47.79500 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 64.63500 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 40.11500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 47.79500 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 64.63500 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 40.11500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 47.79500 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL

REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.

REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000

REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 HOH A2073 LIES ON A SPECIAL POSITION.

REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, GLU 94 TO GLN

REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLN A 113 - O HOH A 2132 2.18 REMARK 500 O HOH A 2141 - O HOH A 2323 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 276 CB - CG - OD2 ANGL. DEV. = 6.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 38 -138.52 54.89 REMARK 500 GLN A 94 12.66 -143.83 REMARK 500 SER A 126 -168.13 -168.91 REMARK 500 ASP A 193 0.75 -62.75 REMARK 500 ASP A 205 -165.69 -121.14 REMARK 500 GLU A 249 -3.39 75.91 REMARK 500 LYS A 288 -114.79 63.90 REMARK 500 ASN A 296 28.75 -142.79 REMARK 500 REMARK 500 REMARK: NULL

REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 THE FOLLOWING SOLVENT MOLECULES LIE FARTHER THAN EXPECTED REMARK 525 FROM THE PROTEIN OR NUCLEIC ACID MOLECULE AND MAY BE REMARK 525 ASSOCIATED WITH A SYMMETRY RELATED MOLECULE (M=MODEL REMARK 525 NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 THESE MOLECULES CAN BE PLACED WITHIN 5.00 ANGSTROM OF THE REMARK 525 OBSERVED OLIGOMER BY APPLYING THE SYMMETRY TRANSFORMATION REMARK 525 INDICATED. REMARK 525 REMARK 525 M RES CSSEQI ORIGINAL COORDINATES SYMMETRY TRANS. DIST. REMARK 525 X Y Z REMARK 525 1 HOH Z 90 77.926 4.168 48.619 007 655 2.64

REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 DGL A 1343 REMARK 610 AMV A 1341 REMARK 610 AMV A 1345 REMARK 610 ALA A 2346

REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: DSSP REMARK 700 THE SHEETS PRESENTED AS "AA" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 10-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 11-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL.

REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAG A1340 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AMV A1341 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ALA A2342 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DGL A1343 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAG A1344 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AMV A1345 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ALA A2346 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FMT A1347

REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1H09 RELATED DB: PDB REMARK 900 MULTIMODULAR PNEUMOCOCCAL CELL WALL ENDOLYSIN REMARK 900 FROM PHAGE CP-1 REMARK 900 RELATED ID: 1OBA RELATED DB: PDB REMARK 900 MULTIMODULAR PNEUMOCOCCAL CELL WALL ENDOLYSIN REMARK 900 FROM PHAGE CP-1 COMPLEXED WITH CHOLINE REMARK 900 RELATED ID: 2IXU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MODULAR CPL-1 REMARK 900 ENDOLYSIN COMPLEXED WITH A PEPTIDOGLYCAN REMARK 900 ANALOGUE (WILD-TYPE ENDOLYSIN) REMARK 900 RELATED ID: 2IXV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MODULAR CPL-1 REMARK 900 ENDOLYSIN COMPLEXED WITH A PEPTIDOGLYCAN REMARK 900 ANALOGUE (E94Q MUTANT) REMARK 900 RELATED ID: 2J8G RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MODULAR CPL-1 REMARK 900 ENDOLYSIN COMPLEXED WITH A PEPTIDOGLYCAN REMARK 900 ANALOGUE (E94Q MUTANT IN COMPLEX WITH A REMARK 900 TETRASACCHARIDE-PENTAPEPTIDE)

DBREF 2J8F A 1 339 UNP P15057 LYS_BPCP1 1 339

SEQADV 2J8F GLN A 94 UNP P15057 GLU 94 ENGINEERED MUTATION

SEQRES 1 A 339 MET VAL LYS LYS ASN ASP LEU PHE VAL ASP VAL SER SER SEQRES 2 A 339 HIS ASN GLY TYR ASP ILE THR GLY ILE LEU GLU GLN MET SEQRES 3 A 339 GLY THR THR ASN THR ILE ILE LYS ILE SER GLU SER THR SEQRES 4 A 339 THR TYR LEU ASN PRO CYS LEU SER ALA GLN VAL GLU GLN SEQRES 5 A 339 SER ASN PRO ILE GLY PHE TYR HIS PHE ALA ARG PHE GLY SEQRES 6 A 339 GLY ASP VAL ALA GLU ALA GLU ARG GLU ALA GLN PHE PHE SEQRES 7 A 339 LEU ASP ASN VAL PRO MET GLN VAL LYS TYR LEU VAL LEU SEQRES 8 A 339 ASP TYR GLN ASP ASP PRO SER GLY ASP ALA GLN ALA ASN SEQRES 9 A 339 THR ASN ALA CYS LEU ARG PHE MET GLN MET ILE ALA ASP SEQRES 10 A 339 ALA GLY TYR LYS PRO ILE TYR TYR SER TYR LYS PRO PHE SEQRES 11 A 339 THR HIS ASP ASN VAL ASP TYR GLN GLN ILE LEU ALA GLN SEQRES 12 A 339 PHE PRO ASN SER LEU TRP ILE ALA GLY TYR GLY LEU ASN SEQRES 13 A 339 ASP GLY THR ALA ASN PHE GLU TYR PHE PRO SER MET ASP SEQRES 14 A 339 GLY ILE ARG TRP TRP GLN TYR SER SER ASN PRO PHE ASP SEQRES 15 A 339 LYS ASN ILE VAL LEU LEU ASP ASP GLU GLU ASP ASP LYS SEQRES 16 A 339 PRO LYS THR ALA GLY THR TRP LYS GLN ASP SER LYS GLY SEQRES 17 A 339 TRP TRP PHE ARG ARG ASN ASN GLY SER PHE PRO TYR ASN SEQRES 18 A 339 LYS TRP GLU LYS ILE GLY GLY VAL TRP TYR TYR PHE ASP SEQRES 19 A 339 SER LYS GLY TYR CYS LEU THR SER GLU TRP LEU LYS ASP SEQRES 20 A 339 ASN GLU LYS TRP TYR TYR LEU LYS ASP ASN GLY ALA MET SEQRES 21 A 339 ALA THR GLY TRP VAL LEU VAL GLY SER GLU TRP TYR TYR SEQRES 22 A 339 MET ASP ASP SER GLY ALA MET VAL THR GLY TRP VAL LYS SEQRES 23 A 339 TYR LYS ASN ASN TRP TYR TYR MET THR ASN GLU ARG GLY SEQRES 24 A 339 ASN MET VAL SER ASN GLU PHE ILE LYS SER GLY LYS GLY SEQRES 25 A 339 TRP TYR PHE MET ASN THR ASN GLY GLU LEU ALA ASP ASN SEQRES 26 A 339 PRO SER PHE THR LYS GLU PRO ASP GLY LEU ILE THR VAL SEQRES 27 A 339 ALA

HET NAG A1340 14 HET AMV A1341 20 HET ALA A2342 5 HET DGL A1343 9 HET NAG A1344 14 HET AMV A1345 20 HET ALA A2346 5 HET FMT A1347 3

HETNAM FMT FORMIC ACID HETNAM DGL D-GLUTAMIC ACID HETNAM AMV METHYL 2-(ACETYLAMINO)-3-O-[(1R)-1- HETNAM 2 AMV CARBOXYETHYL]-2-DEOXY-BETA-D-GLUCOPYRANOSIDE HETNAM NAG N-ACETYL-D-GLUCOSAMINE HETNAM ALA ALANINE

HETSYN NAG NAG

FORMUL 2 FMT C H2 O2 FORMUL 3 DGL C5 H9 N O4 FORMUL 4 AMV 2(C12 H21 N1 O8) FORMUL 5 NAG 2(C8 H15 N O6) FORMUL 6 ALA 2(C3 H7 N O2) FORMUL 7 HOH *333(H2 O1)

HELIX 1 1 SER A 12 GLY A 16 5 5 HELIX 2 2 ILE A 19 GLY A 27 1 9 HELIX 3 3 CYS A 45 GLN A 52 1 8 HELIX 4 4 ASP A 67 ASN A 81 1 15 HELIX 5 5 ASP A 100 ALA A 118 1 19 HELIX 6 6 LYS A 128 VAL A 135 1 8 HELIX 7 7 ASP A 136 PHE A 144 1 9 HELIX 8 8 ASN A 161 PHE A 165 5 5 HELIX 9 9 ASN A 296 ASN A 300 5 5

SHEET 1 AA11 LEU A 7 VAL A 11 0 SHEET 2 AA11 ASP A 182 VAL A 186 -1 O ASP A 182 N ASP A 10 SHEET 3 AA11 ILE A 171 SER A 177 -1 O TRP A 174 N ILE A 185 SHEET 4 AA11 LEU A 148 ALA A 151 1 O LEU A 148 N ARG A 172 SHEET 5 AA11 LYS A 121 TYR A 127 1 O TYR A 124 N TRP A 149 SHEET 6 AA11 TYR A 88 ASP A 92 1 O LEU A 89 N ILE A 123 SHEET 7 AA11 ASN A 54 PHE A 61 1 O ILE A 56 N TYR A 88 SHEET 8 AA11 ASN A 30 GLU A 37 4 O THR A 31 N ILE A 56 SHEET 9 AA11 LEU A 7 VAL A 11 1 O VAL A 9 N ILE A 32 SHEET 10 AA11 ASP A 182 VAL A 186 -1 O ASP A 182 N ASP A 10 SHEET 11 AA11 LEU A 7 VAL A 11 -1 O PHE A 8 N ASN A 184 SHEET 1 AB 2 GLY A 200 GLN A 204 0 SHEET 2 AB 2 TRP A 209 ARG A 213 -1 O TRP A 210 N LYS A 203 SHEET 1 AC 2 LYS A 222 ILE A 226 0 SHEET 2 AC 2 VAL A 229 PHE A 233 -1 O VAL A 229 N ILE A 226 SHEET 1 AD 2 GLU A 243 ASP A 247 0 SHEET 2 AD 2 LYS A 250 LEU A 254 -1 O LYS A 250 N ASP A 247 SHEET 1 AE 2 GLY A 263 VAL A 267 0 SHEET 2 AE 2 GLU A 270 MET A 274 -1 O GLU A 270 N VAL A 267 SHEET 1 AF 5 GLY A 312 MET A 316 0 SHEET 2 AF 5 VAL A 302 SER A 309 -1 O GLU A 305 N MET A 316 SHEET 3 AF 5 ASN A 290 THR A 295 -1 O TRP A 291 N PHE A 306 SHEET 4 AF 5 GLY A 283 TYR A 287 -1 O GLY A 283 N MET A 294 SHEET 5 AF 5 LEU A 335 THR A 337 1 O LEU A 335 N LYS A 286

LINK C1 NAG A1340 O4 AMV A1341 1555 1555 1.43 LINK C10 AMV A1341 N ALA A2342 1555 1555 1.37 LINK N DGL A1343 C ALA A2342 1555 1555 1.37 LINK C1 NAG A1344 O4 AMV A1345 1555 1555 1.43 LINK C10 AMV A1345 N ALA A2346 1555 1555 1.37

CISPEP 1 ASN A 179 PRO A 180 0 1.32

SITE 1 AC1 11 GLN A 94 TYR A 125 ALA A 151 ASP A 205 SITE 2 AC1 11 SER A 206 AMV A1341 HOH A2141 HOH A2205 SITE 3 AC1 11 HOH A2209 HOH A2322 HOH A2323 SITE 1 AC2 13 TYR A 127 PRO A 129 ALA A 151 GLY A 152 SITE 2 AC2 13 TYR A 153 NAG A1340 DGL A1343 HOH A2165 SITE 3 AC2 13 HOH A2322 HOH A2324 HOH A2325 HOH A2327 SITE 4 AC2 13 ALA A2342 SITE 1 AC3 4 GLY A 154 AMV A1341 DGL A1343 HOH A2322 SITE 1 AC4 7 GLY A 154 LEU A 155 TYR A 164 AMV A1341 SITE 2 AC4 7 HOH A2326 HOH A2327 ALA A2342 SITE 1 AC5 12 PHE A 165 SER A 167 MET A 168 ASP A 169 SITE 2 AC5 12 GLY A 170 ILE A 171 AMV A1345 HOH A2162 SITE 3 AC5 12 HOH A2176 HOH A2179 HOH A2328 HOH A2329 SITE 1 AC6 7 PHE A 162 ASP A 169 LYS A 288 NAG A1344 SITE 2 AC6 7 HOH A2330 HOH A2333 ALA A2346 SITE 1 AC7 2 AMV A1345 HOH A2176 SITE 1 AC8 5 SER A 12 SER A 13 LYS A 34 TYR A 41 SITE 2 AC8 5 ARG A 212

CRYST1 80.230 95.590 129.270 90.00 90.00 90.00 C 2 2 21 8

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 0.012464 0.000000 0.000000 0.00000

SCALE2 0.000000 0.010461 0.000000 0.00000

SCALE3 0.000000 0.000000 0.007736 0.00000